Dữ liệu Xếp hạng Học thuật WoS SCIE & CAS
Bảng Xếp hạng Tạp chí Khoa học Toàn cầu
Khám phá thứ bậc học thuật, đối chiếu chỉ số Clarivate Impact Factor, phân hạng Web of Science Q1–Q4 và phân vùng CAS.
Hiển thị 26–50 của 127 tạp chí khoa học quốc tế (Pharmacy)
| Hạng | Tên Tạp chí & Mã ISSN | Impact Factor | H-Index | Phân hạng WoS | Scopus SJR | Phân vùng CAS | Tự trích dẫn | Số bài/năm | Nhà xuất bản |
|---|---|---|---|---|---|---|---|---|---|
| #26 | AAPS Pharmscitech ISSN: 1530-9932 | 5.1 | 130 | Q1 | 0.721Q1 | CAS Tier 3 | 2.9% | 297 | Springer International Publishing |
| #27 | European Journal of Pharmaceutical Sciences ISSN: 0928-0987 / 1879-0720 | 5.1 | 176 | Q1 | 0.951Q1 | CAS Tier 2 | 2.3% | 375 | Elsevier |
| #28 | Expert Opinion on Therapeutic Targets ISSN: 1472-8222 / 1744-7631Top Tier | 5.1 | 120 | Q1 | 1.383Q1 | CAS Tier 3 | 2.2% | 70 | Taylor and Francis Ltd. |
| #29 | European Journal of Pharmaceutics and Biopharmaceutics ISSN: 0939-6411 / 1873-3441 | 5 | 201 | Q1 | 0.848Q1 | CAS Tier 3 | 2.3% | 235 | Elsevier |
| #30 | Biomolecules & Therapeutics ISSN: 1976-9148 / 2005-4483 | 4.9 | 66 | Q1 | 0.969Q2 | CAS Tier 3 | 6.7% | 93 | Korean Society of Applied Pharmacology |
| #31 | Clinical Pharmacology & Therapeutics ISSN: 0009-9236 / 1532-6535Top Tier | 4.9 | 226 | Q1 | 1.856Q1 | CAS Tier 2 | 7.9% | 260 | Wiley-Blackwell |
| #32 | Molecular Pharmaceutics ISSN: 1543-8384 / 1543-8392 | 4.9 | 172 | Q2 | 0.957Q1 | CAS Tier 2 | 6.7% | 384 | American Chemical Society |
| #33 | Advances in Therapy ISSN: 0741-238X / 1865-8652 | 4.7 | 99 | Q2 | 1.418Q1 | CAS Tier 2 | 2.9% | 356 | Springer Healthcare |
| #34 | Drug Metabolism Reviews ISSN: 0360-2532 / 1097-9883Top Tier | 4.7 | 117 | Q1 | 0.93Q1 | CAS Tier 3 | 2.9% | 24 | Informa Healthcare |
| #35 | Expert Opinion on Therapeutic Patents ISSN: 1354-3776 / 1744-7674Top Tier | 4.7 | 98 | Q2 | 1.098Q1 | CAS Tier 3 | 1.9% | 66 | Taylor and Francis Ltd. |
| #36 | Journal of Drug Targeting ISSN: 1061-186X / 1029-2330 | 4.7 | 116 | Q1 | 0.829Q1 | CAS Tier 3 | 0% | 80 | Informa Healthcare |
| #37 | Pharmacoeconomics ISSN: 1170-7690 / 1179-2027 | 4.7 | 127 | Q1 | 1.807Q1 | CAS Tier 2 | 9.1% | 108 | Springer International Publishing |
| #38 | Expert Review of Anti-Infective Therapy ISSN: 1478-7210 / 1744-8336Top Tier | 4.6 | 110 | Q1 | 1.024Q1 | CAS Tier 3 | 2.4% | 116 | Taylor and Francis Ltd. |
| #39 | Pharmacological Reports ISSN: 1734-1140 / 2299-5684 | 4.5 | 104 | Q2 | 1.016Q1 | CAS Tier 3 | 0% | 135 | Springer International Publishing |
| #40 | Expert Opinion on Investigational Drugs ISSN: 1354-3784 / 1744-7658Top Tier | 4.3 | 126 | Q2 | 1.199Q1 | CAS Tier 3 | 0% | 97 | Taylor and Francis Ltd. |
| #41 | Journal of Pharmacology and Experimental Therapeutics ISSN: 0022-3565 / 1521-0103 | 4.3 | 254 | Q2 | 0.921Q2 | CAS Tier 3 | 6.5% | 145 | American Society for Pharmacology and Experimental Therapeutics |
| #42 | Clinical Pharmacokinetics ISSN: 0312-5963 / 1179-1926 | 4 | 197 | Q2 | 1.211Q1 | CAS Tier 2 | 4.3% | 113 | Springer International Publishing |
| #43 | Naunyn-Schmiedebergs Archives of Pharmacology ISSN: 0028-1298 / 1432-1912 | 4 | 104 | Q2 | 0.877Q2 | CAS Tier 3 | 6.5% | 134 | Springer Berlin Heidelberg |
| #44 | Pharmacotherapy ISSN: 0277-0008 / 1875-9114 | 4 | 136 | Q2 | 1.189Q1 | CAS Tier 3 | 6.9% | 102 | Wiley-Blackwell |
| #45 | Expert Opinion on Emerging Drugs ISSN: 1472-8214 / 1744-7623Top Tier | 3.8 | 59 | Q2 | 0.908Q2 | CAS Tier 3 | 0% | 31 | Taylor and Francis Ltd. |
| #46 | Clinical Therapeutics ISSN: 0149-2918 / 1879-114X | 3.7 | 158 | Q2 | 1.041Q1 | CAS Tier 3 | 0% | 169 | Elsevier Inc. |
| #47 | Journal of Natural Products ISSN: 0163-3864 / 1520-6025Top Tier | 3.7 | 173 | Q2 | 0.585Q1 | CAS Tier 2 | 6.1% | 351 | American Chemical Society |
| #48 | Journal of Pharmacy and Pharmacology ISSN: 0022-3573 / 2042-7158 | 3.7 | 148 | Q2 | 0.765Q2 | CAS Tier 3 | 0% | 193 | Wiley-Blackwell |
| #49 | Vascular Pharmacology ISSN: 1537-1891 / 1879-3649 | 3.7 | 114 | Q2 | 0.99Q2 | CAS Tier 3 | 2.9% | 66 | Elsevier Inc. |
| #50 | Drug Metabolism and Disposition ISSN: 0090-9556 / 1521-009X | 3.6 | 202 | Q2 | 1.054Q1 | CAS Tier 3 | 15.9% | 99 | American Society for Pharmacology and Experimental Therapeutics |